Document Detail


Learning from product labels and label changes: how to build pharmacogenomics into drug-development programs.
MedLine Citation:
PMID:  21142906     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
The 2010 US FDA-Drug Industry Association (DIA) Pharmacogenomics (PGx) Workshop follows a series that began in 2002 bringing together multidisciplinary experts spanning regulatory authorities, medical research, healthcare and industry. This report summarizes the 'Building PGx into Labels' sessions from the workshop, which discussed the critical elements in developing PGx outcomes leading to product labels that inform efficacy and/or safety. Examples were drawn from US prescribing information, which integrated PGx knowledge into medical decisions (e.g., panitumumab, warfarin and clopidogrel). Attendees indicated the need for broader dialog and for guidelines on evidentiary considerations for PGx to be included into product labels. Also discussed was the understanding of appropriate PGx placement on labels; how to encourage adoption by medical communities of label recommendations on PGx tests; and, given the global nature of drug development, worldwide considerations including European Summary of Product Characteristics.
Authors:
Linda C Surh; Michael A Pacanowski; Susanne B Haga; Stuart Hobbs; Lawrence J Lesko; Scott Gottlieb; Marisa Papaluca-Amati; Scott D Patterson; Arlene R Hughes; Myong-Jin Kim; Sandra L Close; Michael Mosteller; Issam Zineh; Bryan Dechairo; Nadine A Cohen
Related Documents :
8829686 - Gender differences in cardiovascular outcomes.
942816 - Peer review and psro: an update.
11867426 - Standards for psychiatry clerkship directors.
6753556 - Jacob mendez dacosta: medical teacher, clinician, and clinical investigator.
15590526 - Poliosis associated with treatment of fungal endophthalmitis.
3623576 - Accidental poisoning in childhood: a multicentre survey. 2. the role of packaging in ac...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Pharmacogenomics     Volume:  11     ISSN:  1744-8042     ISO Abbreviation:  Pharmacogenomics     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-12-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100897350     Medline TA:  Pharmacogenomics     Country:  England    
Other Details:
Languages:  eng     Pagination:  1637-47     Citation Subset:  IM    
Affiliation:
Global Regulatory Affairs, GlaxoSmithKline, UK. lcsurh@gmail.com.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Generating and weighing evidence in drug development and regulatory decision making: 5th US FDA-DIA ...
Next Document:  Enabling pharmacogenomic clinical trials through sampling.